Yes everyone has an opinion, and the collective opinion of investors is what determines the market cap. Right now, NNVC hasn't shown enough for investors to really buy the story. It remains a great story, if they can start to deliver. I agree that right now, they haven't delivered all that much, just slow and steady progress towards their goals - getting the cides into humans to show they are safe and effective. What's one more year to wait for this incredible potential?
Yes, if it takes one more year I will be surprised. I think things are going to burst in about a month- or less.
I expect a few stages in the rocket launch. First, when the contract is signed with the lab for EBOLACIDE.
Next when preliminary results of that testing surface.
Next when it is clear that the first sample sent to tox studies for FLUcide is followed by a second and third and so on, showing their capacity to produce flucide samples is robust.
Fourth as the EBOLAcide starts showing real promise and the world turns their eyes on Sheldon, Connecticut
and Finally, when Ebolacide is clearly proven to be successful in animals, primates, and humans.
Then, of course, flu season hits with a vengeance... and on and on it goes.
Too good to be true- maybe. But then, maybe not. Also, too bad to be true- unfortunately, for those in the trouble spots.
Market Data 
Markets 
AI
